| Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P … M Venkatesan, NB Gadalla, K Stepniewska, P Dahal, C Nsanzabana, ... The American journal of tropical medicine and hygiene 91 (4), 833, 2014 | 287 | 2014 |
| The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa C Sisowath, PE Ferreira, LY Bustamante, S Dahlström, A Mårtensson, ... Tropical Medicine & International Health 12 (6), 736-742, 2007 | 212 | 2007 |
| Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes AI Nilsson, A Zorzet, A Kanth, S Dahlström, OG Berg, DI Andersson Proceedings of the National Academy of Sciences 103 (18), 6976-6981, 2006 | 165 | 2006 |
| Plasmodium falciparum Multidrug Resistance Protein 1 and Artemisinin-Based Combination Therapy in Africa S Dahlström, PE Ferreira, MI Veiga, N Sedighi, L Wiklund, A Mårtensson, ... The Journal of infectious diseases 200 (9), 1456-1464, 2009 | 113 | 2009 |
| Diversity of the sarco/endoplasmic reticulum Ca2+-ATPase orthologue of Plasmodium falciparum (PfATP6) S Dahlström, MI Veiga, P Ferreira, A Mårtensson, A Kaneko, B Andersson, ... Infection, Genetics and Evolution 8 (3), 340-345, 2008 | 85 | 2008 |
| Polymorphism in PfMRP1 (Plasmodium falciparum Multidrug Resistance Protein 1) Amino Acid 1466 Associated with Resistance to Sulfadoxine-Pyrimethamine … S Dahlström, MI Veiga, A Mårtensson, A Björkman, JP Gil Antimicrobial agents and chemotherapy 53 (6), 2553-2556, 2009 | 80 | 2009 |
| Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania SF Hietala, A Mårtensson, B Ngasala, S Dahlström, N Lindegårdh, ... Antimicrobial agents and chemotherapy 54 (11), 4780-4788, 2010 | 63 | 2010 |
| Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate–amodiaquine fixed dose combination or artemether … SD Otienoburu, O Maïga-Ascofaré, B Schramm, V Jullien, JJ Jones, ... Malaria journal 15, 1-6, 2016 | 47 | 2016 |
| High-Throughput Analysis of Antimalarial Susceptibility Data by the WorldWide Antimalarial Resistance Network (WWARN) In Vitro Analysis and Reporting Tool CJ Woodrow, S Dahlström, R Cooksey, JA Flegg, H Le Nagard, F Mentré, ... Antimicrobial agents and chemotherapy 57 (7), 3121-3130, 2013 | 44 | 2013 |
| Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response MI Veiga, NS Osório, PE Ferreira, O Franzén, S Dahlstrom, JK Lum, ... Antimicrobial agents and chemotherapy 58 (12), 7390-7397, 2014 | 43 | 2014 |
| Plasmodium falciparum Polymorphisms Associated with Ex Vivo Drug Susceptibility and Clinical Effectiveness of Artemisinin-Based Combination Therapies in Benin S Dahlström, A Aubouy, O Maïga-Ascofaré, JF Faucher, A Wakpo, ... Antimicrobial agents and chemotherapy 58 (1), 1-10, 2014 | 36 | 2014 |
| Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria AM Carlsson, BE Ngasala, S Dahlström, C Membi, IM Veiga, L Rombo, ... Malaria journal 10, 1-12, 2011 | 33 | 2011 |
| Chloroquine-resistant malaria in travelers returning from Haiti after 2010 earthquake M Gharbi, DR Pillai, R Lau, V Hubert, K Khairnar, A Existe, E Kendjo, ... Emerging infectious diseases 18 (8), 1346, 2012 | 27 | 2012 |
| Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020 JA Flegg, GS Humphreys, B Montanez, T Strickland, ZJ Jacome-Meza, ... PLOS Computational Biology 18 (8), e1010317, 2022 | 26 | 2022 |
| An online mapping database of molecular markers of drug resistance in Plasmodium falciparum: the ACT Partner Drug Molecular Surveyor SD Otienoburu, I Suay, S Garcia, NV Thomas, S Srisutham, A Björkman, ... Malaria journal 18, 1-10, 2019 | 25 | 2019 |
| Plasmodium falciparum K13 expression associated with parasite clearance during artemisinin-based combination therapy M Silva, PE Ferreira, SD Otienoburu, C Calçada, B Ngasala, A Björkman, ... Journal of Antimicrobial Chemotherapy 74 (7), 1890-1893, 2019 | 20 | 2019 |
| Role of PfATP6 and pfMRP1 in Plasmodium Falciparum Resistance to Antimalarial Drugs S Dahlström PQDT-Global, 2009 | 9 | 2009 |
| Asaq Molecular Marker Study Group Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect … M Venkatesan, NB Gadalla, K Stepniewska, P Dahal, C Nsanzabana, ... Am J Trop Med Hyg 91 (4), 833-843, 2014 | 8 | 2014 |
| Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in Burkina Faso: a … P Sondo, MC Tahita, H Ilboudo, T Rouamba, K Derra, G Tougri, ... Archives of Public Health 80 (1), 41, 2022 | 4 | 2022 |
| Plasmodium falciparum Drug Resistance Genes pfmdr1 and pfcrt In Vivo Co-Expression During Artemether-Lumefantrine Therapy M Silva, M Malmberg, SD Otienoburu, A Björkman, B Ngasala, ... Frontiers in Pharmacology 13, 868723, 2022 | 2 | 2022 |
Jose Pedro GilPrincipal Investigator, Karolinska Institutet在 ki.se 的电子邮件经过验证
